Log in
NASDAQ:GDRX

GoodRx Stock Forecast, Price & News

$48.39
-1.39 (-2.79 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$46.81
Now: $48.39
$49.78
50-Day Range N/A
52-Week Range
$45.50
Now: $48.39
$64.22
Volume1.90 million shs
Average Volume2.47 million shs
Market Capitalization$18.54 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.11 out of 5 stars

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GDRX
CUSIPN/A
CIKN/A
Phone855-268-2822
Employees338

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$18.54 billion
Next Earnings Date11/12/2020 (Confirmed)
OptionableNot Optionable
$48.39
-1.39 (-2.79 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GoodRx (NASDAQ:GDRX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of GoodRx?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoodRx in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for GoodRx
.

When is GoodRx's next earnings date?

GoodRx is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for GoodRx
.

How can I listen to GoodRx's earnings call?

GoodRx will be holding an earnings conference call on Thursday, November 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for GDRX?

13 equities research analysts have issued twelve-month price targets for GoodRx's stock. Their forecasts range from $48.00 to $70.00. On average, they anticipate GoodRx's stock price to reach $58.38 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts' price targets for GoodRx
.

Who are some of GoodRx's key competitors?

What other stocks do shareholders of GoodRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoodRx investors own include Gilead Sciences (GILD), NVIDIA (NVDA), AbbVie (ABBV), Bristol-Myers Squibb (BMY), DraftKings (DKNG), GW Pharmaceuticals (GWPH), Rocket Companies (RKT), AT&T (T), Advanced Micro Devices (AMD) and Alteryx (AYX).

When did GoodRx IPO?

(GDRX) raised $900 million in an initial public offering on Wednesday, September 23rd 2020. The company issued 34,600,000 shares at $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays acted as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers.

What is GoodRx's stock symbol?

GoodRx trades on the NASDAQ under the ticker symbol "GDRX."

When does the company's quiet period expire?

GoodRx's quiet period expires on Monday, November 2nd. GoodRx had issued 34,615,384 shares in its initial public offering on September 23rd. The total size of the offering was $1,142,307,672 based on an initial share price of $33.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Who are GoodRx's major shareholders?

GoodRx's stock is owned by many different institutional and retail investors. Top institutional shareholders include Community Capital Management Inc. (0.00%), Asset Management Corp IL ADV (0.00%), Avestar Capital LLC (0.00%), KG&L Capital Management LLC (0.00%), Emerald Advisers LLC (0.00%) and Evolution Wealth Advisors LLC (0.00%).

Which major investors are buying GoodRx stock?

GDRX stock was purchased by a variety of institutional investors in the last quarter, including Community Capital Management Inc., Asset Management Corp IL ADV, Avestar Capital LLC, KG&L Capital Management LLC, Emerald Advisers LLC, Evolution Wealth Advisors LLC, and Crewe Advisors LLC.

How do I buy shares of GoodRx?

Shares of GDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GoodRx's stock price today?

One share of GDRX stock can currently be purchased for approximately $48.39.

How big of a company is GoodRx?

GoodRx has a market capitalization of $18.54 billion. GoodRx employs 338 workers across the globe.

What is GoodRx's official website?

The official website for GoodRx is www.goodrx.com.

How can I contact GoodRx?

GoodRx's mailing address is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. The company can be reached via phone at 855-268-2822 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.